Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sleep Disruption Pattern - Epilepsy Monitoring Unit

NCT: NCT06581133 · NOT_YET_RECRUITING

NCT IDNCT06581133
StatusNOT_YET_RECRUITING
Start Date2026-10-01
Completion2027-12-01
SponsorDuke University (OTHER)
First posted
Last updated

Brief Summary

Epilepsy affects millions worldwide, with 40% of patients experiencing uncontrolled seizures despite medication. Comprehensive epilepsy centers recommend continuous video-electroencephalography monitoring to define seizure type and distinguish mimickers. This process, however, is resource-intensive, with lengthy hospital stays. The investigators' recent study identified a heightened association between arousals and epileptic activity in drug-resistant focal epilepsy patients. Building on these findings, the investigators aim to explore whether disrupting sleep with an alarm system triggers earlier occurrence of seizures, potentially offering insights to reduce hospital stay durations in epilepsy monitoring units.

Frequently Asked Questions

What is Sleep Disruption Pattern - Epilepsy Monitoring Unit?

Sleep Disruption Pattern - Epilepsy Monitoring Unit is a clinical trial registered under NCT06581133. Current status: NOT_YET_RECRUITING.

What is the status of NCT06581133?

The current status of NCT06581133 (Sleep Disruption Pattern - Epilepsy Monitoring Unit) is: NOT_YET_RECRUITING.

When did Sleep Disruption Pattern - Epilepsy Monitoring Unit start?

Sleep Disruption Pattern - Epilepsy Monitoring Unit started on 2026-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.